Digital It’s time for more tech and biotech innovation in 2023 The drive to make the UK a ‘scientific powerhouse’ was central to the government’s
Views & Analysis Addressing leadership barriers for women in tech and pharma Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.